Chattem Sanofi Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHATTEM SANOFI, and what generic alternatives to CHATTEM SANOFI drugs are available?
CHATTEM SANOFI has eighteen approved drugs.
There are two US patents protecting CHATTEM SANOFI drugs.
There are sixty-seven patent family members on CHATTEM SANOFI drugs in forty countries and two supplementary protection certificates in two countries.
Summary for Chattem Sanofi
International Patents: | 67 |
US Patents: | 2 |
Tradenames: | 15 |
Ingredients: | 7 |
NDAs: | 18 |
Drugs and US Patents for Chattem Sanofi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Chattem Sanofi | CHILDREN'S ALLEGRA HIVES | fexofenadine hydrochloride | SUSPENSION;ORAL | 201373-002 | Jan 24, 2011 | DISCN | Yes | No | 8,933,097 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Chattem Sanofi | CHILDREN'S ALLEGRA HIVES | fexofenadine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021909-003 | Jan 24, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Chattem Sanofi | XYZAL ALLERGY 24HR | levocetirizine dihydrochloride | SOLUTION;ORAL | 209090-001 | Jan 31, 2017 | OTC | Yes | Yes | 8,633,194 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Chattem Sanofi | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-004 | Aug 2, 1996 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chattem Sanofi
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | SUSPENSION;ORAL | 021963-001 | Oct 16, 2006 | 6,399,632 | ⤷ Sign Up |
Chattem Sanofi | XYZAL | levocetirizine dihydrochloride | SOLUTION;ORAL | 022157-001 | Jan 28, 2008 | 5,698,558*PED | ⤷ Sign Up |
Chattem Sanofi | ALLEGRA | fexofenadine hydrochloride | CAPSULE;ORAL | 020625-001 | Jul 25, 1996 | 7,138,524*PED | ⤷ Sign Up |
Chattem Sanofi | CHILDREN'S ALLEGRA ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 020872-005 | Jan 24, 2011 | 5,578,610*PED | ⤷ Sign Up |
Chattem Sanofi | NICODERM CQ | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020165-005 | Aug 2, 1996 | 9,205,059 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CHATTEM SANOFI drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Transdermal System | 7 mg/24 hrs, 14 mg/24 hrs, and 21 mg/24 hrs | ➤ Subscribe | 2014-05-30 |
➤ Subscribe | Tablets | 5 mg | ➤ Subscribe | 2007-12-17 |
➤ Subscribe | Oral Suspension | 30 mg/5 mL | ➤ Subscribe | 2010-01-25 |
➤ Subscribe | Oral Solution | 0.5 mg/mL | ➤ Subscribe | 2009-01-14 |
➤ Subscribe | Tablets | 150 mg | ➤ Subscribe | 2007-10-30 |
International Patents for Chattem Sanofi Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Ecuador | SP088532 | ⤷ Sign Up |
Austria | E443512 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2006005507 | ⤷ Sign Up |
Russian Federation | 2008128418 | ⤷ Sign Up |
Taiwan | I304339 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chattem Sanofi Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0663828 | C300085 | Netherlands | ⤷ Sign Up | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
0058146 | 2001C/045 | Belgium | ⤷ Sign Up | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.